Henry Schein, Inc. (NASDAQ:HSIC) Position Increased by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 3.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,491 shares of the company’s stock after acquiring an additional 497 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Henry Schein were worth $934,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Cromwell Holdings LLC boosted its stake in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the period. Studio Investment Management LLC boosted its position in shares of Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock worth $341,000 after buying an additional 172 shares during the period. Central Pacific Bank Trust Division grew its holdings in shares of Henry Schein by 2.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after buying an additional 200 shares in the last quarter. Huntington National Bank raised its position in Henry Schein by 16.8% during the third quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after buying an additional 218 shares during the period. Finally, Bridge Creek Capital Management LLC lifted its stake in Henry Schein by 0.7% in the 4th quarter. Bridge Creek Capital Management LLC now owns 38,763 shares of the company’s stock worth $2,682,000 after acquiring an additional 260 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Price Performance

NASDAQ HSIC opened at $77.48 on Wednesday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock’s 50-day moving average is $73.80 and its two-hundred day moving average is $71.90. The firm has a market cap of $9.66 billion, a P/E ratio of 31.88, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Insider Activity

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.14% of the stock is currently owned by insiders.

Analyst Ratings Changes

HSIC has been the topic of several research analyst reports. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Jefferies Financial Group boosted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Barrington Research boosted their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $80.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.